Bukwang Pharmaceutical Statistics

Total Valuation

KRX:003000 has a market cap or net worth of KRW 275.87 billion. The enterprise value is 223.65 billion.

Market Cap	275.87B
Enterprise Value	223.65B

Important Dates

The last earnings date was Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:003000 has 68.45 million shares outstanding. The number of shares has decreased by -0.13% in one year.

Current Share Class	68.45M
Shares Outstanding	68.45M
Shares Change (YoY)	-0.13%
Shares Change (QoQ)	+0.98%
Owned by Insiders (%)	19.14%
Owned by Institutions (%)	3.07%
Float	47.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.59
PB Ratio	1.13
P/TBV Ratio	1.16
P/FCF Ratio	11.07
P/OCF Ratio	9.56
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.02, with an EV/FCF ratio of 8.97.

EV / Earnings	-279.92
EV / Sales	1.29
EV / EBITDA	20.02
EV / EBIT	32.58
EV / FCF	8.97

Financial Position

The company has a current ratio of 5.86, with a Debt / Equity ratio of 0.33.

Current Ratio	5.86
Quick Ratio	4.48
Debt / Equity	0.33
Debt / EBITDA	7.58
Debt / FCF	3.22
Interest Coverage	0.96

Financial Efficiency

Return on equity (ROE) is -0.42% and return on invested capital (ROIC) is 1.23%.

Return on Equity (ROE)	-0.42%
Return on Assets (ROA)	0.98%
Return on Invested Capital (ROIC)	1.23%
Return on Capital Employed (ROCE)	1.86%
Revenue Per Employee	286.30M
Profits Per Employee	-1.32M
Employee Count	606
Asset Turnover	0.44
Inventory Turnover	2.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.79% in the last 52 weeks. The beta is 0.84, so KRX:003000's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-29.79%
50-Day Moving Average	3,892.35
200-Day Moving Average	4,622.64
Relative Strength Index (RSI)	61.86
Average Volume (20 Days)	103,251

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:003000 had revenue of KRW 173.50 billion and -798.97 million in losses. Loss per share was -12.05.

Revenue	173.50B
Gross Profit	79.28B
Operating Income	6.26B
Pretax Income	-1.17B
Net Income	-798.97M
EBITDA	10.57B
EBIT	6.26B
Loss Per Share	-12.05

Full Income Statement

Balance Sheet

The company has 132.81 billion in cash and 80.16 billion in debt, giving a net cash position of 52.65 billion or 769.19 per share.

Cash & Cash Equivalents	132.81B
Total Debt	80.16B
Net Cash	52.65B
Net Cash Per Share	769.19
Equity (Book Value)	243.74B
Book Value Per Share	3,554.39
Working Capital	171.22B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 28.86 billion and capital expenditures -3.93 billion, giving a free cash flow of 24.93 billion.

Operating Cash Flow	28.86B
Capital Expenditures	-3.93B
Free Cash Flow	24.93B
FCF Per Share	364.18

Full Cash Flow Statement

Margins

Gross margin is 45.69%, with operating and profit margins of 3.61% and -0.46%.

Gross Margin	45.69%
Operating Margin	3.61%
Pretax Margin	-0.67%
Profit Margin	-0.46%
EBITDA Margin	6.09%
EBIT Margin	3.61%
FCF Margin	14.37%

Dividends & Yields

KRX:003000 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.13%
Shareholder Yield	n/a
Earnings Yield	-0.29%
FCF Yield	9.04%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.1.

Last Split Date	Dec 29, 2020
Split Type	Forward
Split Ratio	1.1

Scores

KRX:003000 has an Altman Z-Score of 3.35.

Altman Z-Score	3.35
Piotroski F-Score	n/a